Login to Your Account



Other News To Note


Wednesday, October 23, 2013

• Shire plc, of Dublin, inked an exclusive distribution and supply agreement for Prasco Laboratories, of Cincinnati, to market an authorized generic version of Fosrenol (lanthanum carbonate) chewable tablets. Fosrenol is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription